Cara Therapeutics, Inc.·4

Jun 6, 5:49 PM ET

VOGELBAUM MARTIN 4

4 · Cara Therapeutics, Inc. · Filed Jun 6, 2022

Insider Transaction Report

Form 4
Period: 2022-06-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-02+33,99333,993 total
    Exercise: $8.42Exp: 2032-06-02Common Stock (33,993 underlying)
  • Award

    Common Stock

    2022-06-02+23,75243,912 total
  • Award

    Common Stock

    2022-06-02+11,87655,788 total
Footnotes (3)
  • [F1]Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
  • [F2]Represents a one-time grant of 11,876 RSUs. Each RSU represents the contingent right to receive one share of the common stock of the Issuer. The RSUs are fully vested on the date of grant.
  • [F3]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION